Cytokinetics, Incorporated
CYTK
$38.34
$0.290.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.54% | -12.81% | 6.36% | -4.27% | 70.73% |
| Total Receivables | 317.99% | -87.92% | 6,723.77% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.38% | 3.58% | 129.20% | -39.60% | -41.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.27% | -13.71% | 8.77% | -4.61% | 67.18% |
|
|
|||||
| Total Current Assets | -7.27% | -13.71% | 8.77% | -4.61% | 67.18% |
| Net Property, Plant & Equipment | 1.19% | 2.58% | 0.29% | -1.66% | -2.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.62% | 64.79% | -0.26% | 0.60% | -1.73% |
| Total Assets | -3.04% | -9.82% | -2.39% | -5.76% | 88.57% |
|
|
|||||
| Total Accounts Payable | 16.40% | -31.55% | 75.88% | 22.29% | -26.97% |
| Total Accrued Expenses | 20.66% | -21.63% | 11.03% | 25.15% | -0.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.46% | 5.97% | 1.07% | 1.16% | 0.93% |
| Total Finance Division Other Current Liabilities | -59.17% | 12.77% | 243.78% | -23.17% | 290.14% |
| Total Other Current Liabilities | -59.17% | 12.77% | 243.78% | -23.17% | 290.14% |
| Total Current Liabilities | -17.94% | -11.10% | 63.62% | 6.84% | 15.67% |
|
|
|||||
| Total Current Liabilities | -17.94% | -11.10% | 63.62% | 6.84% | 15.67% |
| Long-Term Debt | 10.75% | -0.52% | 0.72% | 18.60% | 6.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.05% | 0.68% | -1.89% | -1.68% | -1.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.58% | 3.49% | 3.00% | -16.30% | 41.54% |
| Total Liabilities | 4.17% | -0.43% | 6.01% | 2.45% | 17.52% |
|
|
|||||
| Common Stock & APIC | 1.30% | 1.22% | 1.25% | 1.27% | 35.01% |
| Retained Earnings | -4.69% | -5.97% | -5.88% | -6.71% | -6.38% |
| Treasury Stock & Other | -110.23% | -35.57% | -55.49% | 627.10% | -89.61% |
| Total Common Equity | -38.40% | -96.80% | -873.13% | -112.82% | 127.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.40% | -96.80% | -873.13% | -112.82% | 127.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.40% | -96.80% | -873.13% | -112.82% | 127.40% |
|
|
|||||